Global Science, China’s Rise, and European Anxiety
While some talk about global science, China’s skyrocketing investment in its scientific sector is causing real anxiety for Europe.
While some talk about global science, China’s skyrocketing investment in its scientific sector is causing real anxiety for Europe.
TrendMD may drive traffic, saves, and citations, according to a new study by the founders and employees of TrendMD. Deeper analysis of their results reveal overstated results and a lack of context. Should these papers be considered sound science just another form of marketing?
Plan S proposes criteria for the “transformative journal” – how are publishers responding?
A recent opinion paper by Richard Poynder @rickypo offers analysis and prognostication with regard to the current state and future prospects of #openaccess and the open access movement.
The publisher is committed to financial sustainability. How it achieves it is an open question.
Geowalling open content is proposed yet again. As a thought experiment, @lisalibrarian explores what Plan S principles would be compromised by this tactic.
How many articles from predatory journals are being cited in the legitimate (especially medical) literature? Some disturbing findings.
It’s Open Access week so this month we asked the chefs: What’s next for OA? What lies beyond the APC as a funding model? Let us know your thoughts!
Highwire’s Byron Russell reports on this year’s OASPA Conference, and future paths to sustainable open access business models.
The conversation around open access has shifted from “should we?” to “how are we going to?” The failings of the author-pays model are becoming increasingly evident. Finding better models is proving to be both urgently necessary and extremely difficult.
Robert Harington suggests that despite the critical role of scholarly societies in publishing and academia, the sad reality is it is the big corporate publishers who win.
An interview with Springer Nature’s Dagmar Laging about the emerging transformative open access agreement with Germany’s Projekt DEAL.
Scholarly publishing needs a scalable, easily adopted, and industry-wide approach to the problem of author manuscripts including citations to articles in fraudulent journals.
The Washington Post looks at the long history of vaccine skepticism.
Quality means different things to different people. How do you think different stakeholders would define quality in peer review?